Mostrar el registro sencillo del ítem
| dc.contributor.author | Lampousi, Anna-María | |
| dc.contributor.author | Carlsson, Sofia | |
| dc.contributor.author | Lofvenborg, Josefin-E | |
| dc.contributor.author | Cabrera-Castro, Natalia | |
| dc.contributor.author | Chirlaque-López, María-Dolores | |
| dc.contributor.author | Fagherazzi, Guy | |
| dc.contributor.author | Franks, Paul-W | |
| dc.contributor.author | Hampe, Christiane-S | |
| dc.contributor.author | Jakszyn, Paula | |
| dc.contributor.author | Koulman, Albert | |
| dc.contributor.author | Kyro, Cecilie | |
| dc.contributor.author | Moreno-Iribas, Conchi | |
| dc.contributor.author | Nilsson, Peter-M | |
| dc.contributor.author | Panico, Salvatore | |
| dc.contributor.author | Papier, Keren | |
| dc.contributor.author | van-der-Schouw, Yvonne-T | |
| dc.contributor.author | Schulze, Matthias-B | |
| dc.contributor.author | Weiderpass, Elisabete | |
| dc.contributor.author | Zamora-Ros, Raúl | |
| dc.contributor.author | Forouhi, Nita-G | |
| dc.contributor.author | Sharp, Stephen-J | |
| dc.contributor.author | Rolandsson, Olov | |
| dc.contributor.author | Wareham, Nicholas-J | |
| dc.date.accessioned | 2025-11-18T09:30:41Z | |
| dc.date.available | 2025-11-18T09:30:41Z | |
| dc.date.issued | 2023-08 | |
| dc.identifier.citation | Lampousi AM, Carlsson S, Löfvenborg JE, Cabrera-Castro N, Chirlaque MD, Fagherazzi G, et al. Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case¿cohort study. Diabetologia. agosto de 2023;66(8):1460-71. | |
| dc.identifier.issn | 0012-186X | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/20811 | |
| dc.description.abstract | AIMS/HYPOTHESIS: Islet autoimmunity may progress to adult-onset diabetes. We investigated whether circulating odd-chain fatty acids (OCFA) 15:0 and 17:0, which are inversely associated with type 2 diabetes, interact with autoantibodies against GAD65 (GAD65Ab) on the incidence of adult-onset diabetes. METHODS: We used the European EPIC-InterAct case-cohort study including 11,124 incident adult-onset diabetes cases and a subcohort of 14,866 randomly selected individuals. Adjusted Prentice-weighted Cox regression estimated HRs and 95% CIs of diabetes in relation to 1 SD lower plasma phospholipid 15:0 and/or 17:0 concentrations or their main contributor, dairy intake, among GAD65Ab-negative and -positive individuals. Interactions between tertiles of OCFA and GAD65Ab status were estimated by proportion attributable to interaction (AP). RESULTS: Low concentrations of OCFA, particularly 17:0, were associated with a higher incidence of adult-onset diabetes in both GAD65Ab-negative (HR 1.55 [95% CI 1.48, 1.64]) and GAD65Ab-positive (HR 1.69 [95% CI 1.34, 2.13]) individuals. The combination of low 17:0 and high GAD65Ab positivity vs high 17:0 and GAD65Ab negativity conferred an HR of 7.51 (95% CI 4.83, 11.69), with evidence of additive interaction (AP 0.25 [95% CI 0.05, 0.45]). Low dairy intake was not associated with diabetes incidence in either GAD65Ab-negative (HR 0.98 [95% CI 0.94, 1.02]) or GAD65Ab-positive individuals (HR 0.97 [95% CI 0.79, 1.18]). CONCLUSIONS/INTERPRETATION: Low plasma phospholipid 17:0 concentrations may promote the progression from GAD65Ab positivity to adult-onset diabetes. | |
| dc.language.iso | eng | |
| dc.publisher | Springer | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Adult | |
| dc.subject.mesh | Diabetes Mellitus, Type 2 | |
| dc.subject.mesh | Fatty Acids | |
| dc.subject.mesh | Phospholipids | |
| dc.subject.mesh | Cohort Studies | |
| dc.subject.mesh | Incidence | |
| dc.subject.mesh | Autoantibodies | |
| dc.subject.mesh | Glutamate Decarboxylase | |
| dc.title | Interaction between plasma phospholipid odd-chain fatty acids and GAD65 autoantibodies on the incidence of adult-onset diabetes: the EPIC-InterAct case-cohort study | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 37301794 | |
| dc.relation.publisherversion | https://link.springer.com/10.1007/s00125-023-05948-x | |
| dc.identifier.doi | 10.1007/s00125-023-05948-x | |
| dc.journal.title | Diabetologia | |
| dc.identifier.essn | 1432-0428 |